Quantitative Assessment of Levonorgestrel Binding Partner Interplay and Drug‐Drug Interactions Using Physiologically Based Pharmacokinetic Modeling-Reference-Cited by-同舟云学术

Quantitative Assessment of Levonorgestrel Binding Partner Interplay and Drug‐Drug Interactions Using Physiologically Based Pharmacokinetic Modeling

Published:2020-12-13 Issue:1 Volume:10 Page:48-58
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT Pharmacometrics Syst. Pharmacol.

Author:

Cicali Brian¹,Lingineni Karthik¹,Cristofoletti Rodrigo¹,Wendl Thomas²,Hoechel Joachim²,Wiesinger Herbert²,Chaturvedula Ayyappa³,Vozmediano Valvanera¹,Schmidt Stephan¹

Affiliation:

1. Center for Pharmacometrics and Systems Pharmacology Department of Pharmaceutics College of Pharmacy University of Florida Orlando Florida USA

2. Bayer AG Pharmaceuticals Leverkusen Germany

3. Department of Pharmacotherapy System College of Pharmacy University of Northern Texas Health Science Center Fort Worth Texas USA

Funder

Bill and Melinda Gates Foundation

Publisher

Wiley

Subject

Pharmacology (medical),Modeling and Simulation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/psp4.12572

Reference41 articles.

1. The New Extended-Cycle Levonorgestrel-Ethinyl Estradiol Oral Contraceptives

2. The clinical relevance of progestogens in hormonal contraception: Present status and future developments

3. The lowest‐dose, extended‐cycle combined oral contraceptive pill with continuous ethinyl estradiol in the United States: a review of the literature on ethinyl estradiol 20 μg/levonorgestrel 100 μg + ethinyl estradiol 10 μg;Krishnan S.;Int. J. Womens Health,2010

4. The creeping pearl: why has the rate of contraceptive failure increased in clinical trials of combined hormonal contraceptive pills?

5. Public Savings from the Prevention of Unintended Pregnancy: A Cost Analysis of Family Planning Services in California

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physiologically based pharmacokinetic modeling in obesity: applications and challenges;Expert Opinion on Drug Metabolism & Toxicology;2024-08-12

2. Applying Physiologically Based Pharmacokinetic Modeling to Interpret Carbamazepine’s Nonlinear Pharmacokinetics and Its Induction Potential on Cytochrome P450 3A4 and Cytochrome P450 2C9 Enzymes;Pharmaceutics;2024-05-30

3. Physiologically‐based pharmacokinetic modeling of prominent oral contraceptive agents and applications in drug–drug interactions;CPT: Pharmacometrics & Systems Pharmacology;2024-01-15

4. Model-Based Analysis of In Vivo Release Data of Levonorgestrel Implants: Projecting Long-Term Systemic Exposure;Pharmaceutics;2023-05-02

5. Combined Oral Contraceptives As Victims of Drug Interactions;Drug Metabolism and Disposition;2023-03-24